Adaptive radiotherapy in the management of cervical cancer: review of strategies and clinical implementation
dc.contributor.author | Shelley, C. E. | |
dc.contributor.author | Barraclough, Lisa H | |
dc.contributor.author | Nelder, Claire L | |
dc.contributor.author | Otter, S. J | |
dc.contributor.author | Stewart, A. J. | |
dc.date.accessioned | 2021-08-17T12:22:42Z | |
dc.date.available | 2021-08-17T12:22:42Z | |
dc.date.issued | 2021 | en |
dc.identifier.citation | Shelley CE, Barraclough LH, Nelder CL, Otter SJ, Stewart AJ. Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation. Clinical Oncology. 2021 Sep;33(9):579–90. | en |
dc.identifier.pmid | 34247890 | en |
dc.identifier.doi | 10.1016/j.clon.2021.06.007 | en |
dc.identifier.uri | http://hdl.handle.net/10541/624439 | |
dc.description.abstract | The complex and varied motion of the cervix-uterus target during external beam radiotherapy (EBRT) underscores the clinical benefits afforded by adaptive radiotherapy (ART) techniques. These gains have already been realised in the implementation of image-guided adaptive brachytherapy, where adapting to anatomy at each fraction has seen improvements in clinical outcomes and a reduction in treatment toxicity. With regards to EBRT, multiple adaptive strategies have been implemented, including a personalised internal target volume, offline replanning and a plan of the day approach. With technological advances, there is now the ability for real-time online ART using both magnetic resonance imaging and computed tomography-guided imaging. However, multiple challenges remain in the widespread dissemination of ART. This review investigates the ART strategies and their clinical implementation in EBRT delivery for cervical cancer. | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.clon.2021.06.007 | en |
dc.title | Adaptive radiotherapy in the management of cervical cancer: review of strategies and clinical implementation | en |
dc.type | Article | en |
dc.contributor.department | Department of Clinical Oncology, St. Luke's Cancer Centre, Royal Surrey County Hospital, Guildford, UK | en |
dc.identifier.journal | Clinical Oncology | en |
dc.description.note | en] |